A. Basile

发表

Direct and indirect enhancement of GABAergic neurotransmission by ammonia: implications for the pathogenesis of hyperammonemic syndromes

A. Basile, 2002, Neurochemistry International.

Dose-ranging evaluation of intravitreal siRNA PF-04523655 for diabetic macular edema (the DEGAS study).

R. Schachar, Q. Nguyen, C. Nduaka, 2012, Investigative ophthalmology & visual science.

Late evolutionary appearance of ‘peripheral-type’ binding sites for benzodiazepines

S. Paul, J. Barrett, P. Skolnick, 1985, Brain Research.

Intravitreal concentrations of a near-infrared fluorescence-labeled biotherapeutic determined in situ using confocal scanning laser ophthalmoscopy.

T. R. Johnson, M. Shields, A. Basile, 2011, Investigative ophthalmology & visual science.

Behavioral Characterization of Mice Lacking the A3 Adenosine Receptor: Sensitivity to Hypoxic Neurodegeneration

Kenneth A. Jacobson, Anthony Basile, K. Jacobson, 2003, Cellular and Molecular Neurobiology.

Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex

P. Skolnick, A. Basile, B. Weissman, 1987, Brain Research Bulletin.

Characterization of the hypnotic properties of oleamide.

W. Mendelson, A. Basile, L. Hanus, 1999, Neuroreport.

Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems.

D. Boger, M. Hedrick, K. Rice, 2001, The Journal of pharmacology and experimental therapeutics.

Characterization of benzodiazepine receptors in the bovine pineal gland: evidence for the presence of an atypical binding site.

P. Skolnick, D. Klein, A. Basile, 1986, Brain research.

Subcellular Localization of “Peripheral‐Type” Binding Sites for Benzodiazepines in Rat Brain

P. Skolnick, A. Basile, Phil Skolnick, 1986, Journal of neurochemistry.

The pattern of neurotransmitter alterations in LP-BM5 infected mice is consistent with glutamatergic hyperactivation

A. Basile, Y. Sei, M. Espey, 1998, Brain Research.

Multiple [3H]DTG binding sites in guinea pig cerebellum: evidence for the presence of non-specific binding.

I. Paul, B. Decosta, A. Basile, 1994, European journal of pharmacology.

Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells

E. Rojas, P. Skolnick, H. Pollard, 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Differential effects of cytochrome P-450 induction on ligand binding to σ receptors

I. Paul, A. Basile, B. Costa, 1992 .

Ammonia and GABA‐ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy

A. Basile, E. Jones, E. Jones, 1997, Hepatology.

Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy

T. J. Walsh, C. Yurdaydın, T. Walsh, 1995, Brain Research.

Do benzodiazepine ligands contribute to hepatic encephalopathy?

C. Yurdaydın, A. Basile, E. Jones, 1993, Advances in experimental medicine and biology.

Hepatic encephalopathy and the GABA/benzodiazepine receptor‐chloride ionophore complex: An update

A. Basile, E. Jones, E. Jones, 1988 .

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

L. Pannell, P. Skolnick, R. Hughes, 1991, The New England journal of medicine.

The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy

A. Basile, 1991, Synapse.

GABAA Receptor Complex in an Experimental Model of Hepatic Encephalopathy: Evidence for Elevated Levels of an Endogenous Benzodiazepine Receptor Ligand

P. Skolnick, A. Basile, E. A. Jones, 1989, Journal of neurochemistry.

Benzodiazepine-receptor antagonists and hepatic encephalopathy: where do we stand?

A. Basile, K. Mullen, 1993, Gastroenterology.

Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.

P. Skolnick, A. Basile, E. Jones, 1990, Advances in experimental medicine and biology.

Preclinical Evaluation of the Abuse Potential of the Analgesic Bicifadine

P. Skolnick, K. Nicholson, A. Basile, 2009, Journal of Pharmacology and Experimental Therapeutics.

β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)

J. Glass, Bethany L Peterson, R. Bartus, 2016, Neurobiology of Disease.

Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients

R. Schachar, Q. Nguyen, C. Nduaka, 2012, Eye.

Glutamate‐Induced Over‐Expression of GAD Is Down‐Regulated by Acetyl‐L‐Carnitine in Rat Islet Cells

Guang Chen, Lei Zhang, A. Basile, 2004, Endocrine research.

Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis

P. Skolnick, A. Basile, Y. Sei, 1998, Neuroscience Letters.

Striatal Met‐Enkephalin and Substance P Levels Are Decreased in Mice Infected with the LP‐BM5 Murine Leukemia Virus

A. Basile, Y. Sei, J. Ha, 1995, Journal of neurochemistry.

Ethanol tolerance of cerebellar purkinje neurons from selectively outbred mouse lines: in vivo and in vitro electrophysiological investigations.

T. Dunwiddie, M. Palmer, A. Basile, 1985, Alcoholism, clinical and experimental research.

Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats.

P. Skolnick, J. Mamczarz, A. Basile, 2012, Alcoholism, clinical and experimental research.

Saturation Assays of Radioligand Binding to Receptors and Their Allosteric Modulatory Sites

A. Basile, 1997, Current protocols in neuroscience.

N–Methyl–D–aspartate antagonists limit aminoglycoside antibiotic–induced hearing loss

C. Berlin, D. Webster, P. Skolnick, 1996, Nature Medicine.

Mice transgenically overexpressing sulfonylurea receptor 1 in forebrain resist seizure induction and excitotoxic neuron death

D. Leroith, H. Arima, A. Basile, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Modulation of ligand binding to components of the GABAA receptor complex by ammonia: implications for the pathogenesis of hyperammonemic syndromes

A. Basile, J. Ha, 1996, Brain Research.

RTP801 gene expression is differentially upregulated in retinopathy and is silenced by PF-04523655, a 19-Mer siRNA directed against RTP801.

T. R. Johnson, P. Vicini, Dalia Kalabat, 2014, Investigative ophthalmology & visual science.

Pharmacological Properties of DOV 315,090, an ocinaplon metabolite

P. Skolnick, A. Basile, D. Farb, 2008, BMC pharmacology.

Regulation of dihydropyridine calcium antagonist binding sites in the rat hippocampus following neurochemical lesions

S. Paul, A. Janowsky, P. Skolnick, 1987, Journal of neuroscience research.

Extracellular Glutamate Levels Are Chronically Elevated in the Brains of LP‐BM5‐Infected Mice: A Mechanism of Retrovirus‐Induced Encephalopathy

A. Basile, Y. Sei, M. Espey, 1998, Journal of neurochemistry.

Inescapable shock reduces [3H]Ro 5-4864 binding to “peripheral-type” benzodiazepine receptors in the rat

S. Paul, J. Crawley, P. Skolnick, 1986, Pharmacology Biochemistry and Behavior.

Volatile anesthetics bidirectionally and stereospecifically modulate ligand binding to GABA receptors.

P. Skolnick, A. Basile, B. Harris, 1994, European journal of pharmacology.

The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy.

M. Heyes, R. Hughes, R. Williams, 1995, Gastroenterology.

Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain

Kuniaki Saito, A. Basile, Y. Sei, 1996, Neuroscience Letters.

Increased blood–brain barrier permeability in LP-BM5 infected mice is mediated by neuroexcitatory mechanisms

A. Grinberg, A. Basile, Y. Kustova, 1999, Brain Research.

Glutamate augments retrovirus-induced immunodeficiency through chronic stimulation of the hypothalamic-pituitary- adrenal axis.

A. Basile, M. Espey, 1999, Journal of immunology.

Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy

R. Hughes, A. Basile, E. A. Jones, 1994, Hepatology.

NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.

P. Skolnick, A. Basile, K. Mullen, 1989, Annals of internal medicine.

GABAA receptor modulators as anxioselective anxiolytics

P. Skolnick, A. Lippa, A. Basile, 2006 .

Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition.

P. Skolnick, A. Basile, L. Fossom, 1995, Molecular pharmacology.

Characterization of the effects of AHN 086, an irreversible ligand of "peripheral" benzodiazepine receptors, on contraction in guinea-pig atrial and ileal longitudinal smooth muscle.

P. Skolnick, A. Newman, K. Rice, 1989, Canadian journal of physiology and pharmacology.

Characterization of stress-induced alterations in [3H] Ro5-4864 binding to peripheral benzodiazepine receptors in rat heart and kidney

S. Paul, J. Crawley, P. Skolnick, 1988, Pharmacology Biochemistry and Behavior.

Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain.

A. Basile, Y. Sei, K. Nishida, 1996, Neuroscience letters.

Accelerated development of neurochemical and behavioral deficits in LP-BM5 infected mice with targeted deletions of the IFN-γ gene

E. Koustova, H. Morse, A. Basile, 2000, Journal of Neuroimmunology.

The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist.

W. Mendelson, A. Basile, 1999, Neuroreport.

Vivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats

R. Bartus, D. Emerich, R. Dean, 2003, Neuropsychopharmacology.

The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptor ligands.

P. Skolnick, A. Basile, E. Jones, 1991, Pharmacological reviews.

Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy.

L. Pannell, P. Skolnick, H. Fales, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Hepatic Encephalopathy and Benzodiazepine Receptor Ligands

P. Skolnick, A. Basile, K. Mullen, 1989 .

BENZODIAZEPIRE RECEPTOR LIGANDS

P. Skolnick, A. Basile, K. Mullen, 1989 .

Behavioral effects and dopamine antagonist properties of N‐alkylaminobenzazepines

A. Newman, J. Witkin, A. Basile, 1996 .

Molecular basis of peripheral vs central benzodiazepine receptor selectivity in a new class of peripheral benzodiazepine receptor ligands related to alpidem.

T. Langer, A. Cappelli, A. Basile, 1996, Journal of medicinal chemistry.

Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy

P. Skolnick, A. Basile, K. Mullen, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs.

P. Skolnick, A. Basile, R I Fryer, 1993, Journal of medicinal chemistry.

Altered brain fyn kinase in a murine acquired immunodeficiency syndrome

P. Skolnick, I. Paul, L. Whitesell, 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Induction of serine racemase expression and D-serine release from microglia by secreted amyloid precursor protein (sAPP).

S. Barger, Shengzhou or sheng-zhou wu, A. Basile, 2007, Current Alzheimer research.

Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide

S. Barger, W. Griffin, Shengzhou or sheng-zhou wu, 2004, Journal of Neuroinflammation.

Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

K. Giacomini, A. Dahlin, J. Siegenthaler, 2013, Molecular pharmaceutics.

Tissue specific regulation of "peripheral-type" benzodiazepine receptor density after chemical sympathectomy.

P. Skolnick, A. Basile, 1988, Life sciences.

Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.

C. Yurdaydın, R. Rothman, A. Basile, 1995, The Journal of pharmacology and experimental therapeutics.

Does Ammonia Contribute to Increased GABA-ergic Neurotransmission in Liver Failure?

A. Basile, E. Jones, 1998, Metabolic Brain Disease.

The GABA hypothesis--state of the art.

C. Yurdaydın, A. Basile, E. Jones, 1994, Advances in experimental medicine and biology.

Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands

P. Skolnick, A. Basile, S. H. Gammal, 1990, Hepatology.

Preclinical Models of Hepatic Encephalopathy

A. Basile, K. Mullen, 1999, Current protocols in neuroscience.

The Relationship Between Plasma and Brain Quinolinic Acid Levels and the Severity of Hepatic Encephalopathy in Animal Models of Fulminant Hepatic Failure

Kuniaki Saito, M. Heyes, A. Basile, 1995, Journal of neurochemistry.

The involvement of ammonia with the mechanisms that enhance GABA-ergic neurotransmission in hepatic failure.

A. Basile, E. Jones, 1997, Advances in experimental medicine and biology.

Evidence of neuronal degeneration in C57B1/6 mice infected with the LP-BM5 leukemia retrovirus mixture.

A. Basile, Y. Sei, M. Espey, 1998, Molecular and chemical neuropathology.

LP-BM5 MuLV Infection: Impact on the Immune and Central Nervous Systems

A. Basile, Y. Sei, M. Espey, 1998 .

Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice.

Christian C Felder, Nasir Siddiqui, J. Wess, 2002, Molecular pharmacology.

Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice

J. Wess, A. Levey, J. Gomeza, 2002, The Journal of Neuroscience.

Skeletal Muscle Type Ryanodine Receptor Is Involved in Calcium Signaling in Human B Lymphocytes*

A. Basile, Y. Sei, K. Gallagher, 1999, The Journal of Biological Chemistry.

The Influence of a Targeted Deletion of the IFNγ Gene on Emotional Behaviors

H. Morse, A. Basile, Y. Sei, 1998, Brain, Behavior, and Immunity.

Gliosis in the LP-BM5 murine leukemia virus-infected mouse: an animal model of retrovirus-induced dementia

A. Basile, Y. Sei, G. Goping, 1996, Brain Research.

Norepinephrine elicits both excitatory and responses from Purkinje cells in the in vitro rat cerebellar slice

T. Dunwiddie, A. Basile, 1984, Brain Research.

Peripheral benzodiazepine receptors and mitochondrial function

S. Galiègue, P. Casellas, A. Basile, 2002, Neurochemistry International.

Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.

P. Skolnick, A. Basile, G. Bolger, 1989, Journal of Pharmacology and Experimental Therapeutics.

Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086.

R. Moreno-Sánchez, P. Chiang, A. Newman, 1991, Biochemical pharmacology.

Inhibitors of Cyclooxygenase-2, but Not Cyclooxygenase-1 Provide Structural and Functional Protection against Quinolinic Acid-Induced Neurodegeneration

J. Kordower, R. Bartus, E. Chen, 2003, Journal of Pharmacology and Experimental Therapeutics.

Population Pharmacokinetics of Pegaptanib in Patients With Neovascular, Age‐Related Macular Degeneration

M. Hutmacher, K. Kowalski, L. Whitfield, 2012, Journal of clinical pharmacology.

Dizocilpine attenuates streptomycin-induced vestibulotoxicity in rats

Alan M. Brichta, P. Skolnick, A. Brichta, 1999, Neuroscience Letters.

Aminoglycoside neurotoxicity involves NMDA receptor activation

P. Skolnick, J. Segal, A. Basile, 1999, Brain Research.

Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain

P. Skolnick, A. Basile, G. Bolger, 1988, Brain Research.

Modulation of (+)-[3H]pentazocine binding to guinea pig cerebellum by divalent cations.

I. Paul, A. Basile, B. de Costa, 1992, Molecular pharmacology.

Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology

P. Skolnick, A. Basile, H. June, 2012, Pharmacology Biochemistry and Behavior.

Triple reuptake inhibitors ("broad spectrum" antidepressants).

P. Skolnick, A. Basile, 2007, CNS & neurological disorders drug targets.

Triple reuptake inhibitors as antidepressants

P. Skolnick, A. Basile, 2006 .

LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

P. Usherwood, M. Rogawski, E. Koustova, 2001, The Journal of clinical investigation.

Muscarinic Acetylcholine Receptor Knockout Mice

Christian C. Felder, Yinghong Cui, Tsuyoshi Miyakawa, 2004 .

Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M1–M5 Muscarinic Receptor Knock-Out Mice

J. Wess, M. Yamada, J. Gomeza, 2002, The Journal of Neuroscience.

A Murine Model of Retroviral Encephalopathy

A. Basile, Y. Sei, 2001, Current protocols in neuroscience.

Pentoxifylline decreases brain levels of platelet activating factor in murine AIDS.

S. Markey, H. Morse, A. Basile, 1997, European journal of pharmacology.

Increased Brain Levels of Platelet‐Activating Factor in a Murine Acquired Immune Deficiency Syndrome Are NMDA Receptor‐Mediated

P. Skolnick, H. Morse, A. Basile, 1996, Journal of neurochemistry.

Suppression of neurocognitive damage in LP‐BM5‐infected mice with a targeted deletion of the TNF‐α gene

T. Nabeshima, M. Takemura, M. Seishima, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Relevance of glutamate levels in the CSF of patients with HIV-1–associated dementia complex

R. Heaton, R. Ellis, A. Basile, 1999, Neurology.

The Encephalopathy Associated with Murine Acquired Immunodeficiency Syndrome

P. Skolnick, H. Morse, A. Basile, 1998, Annals of the New York Academy of Sciences.

Regional changes in constitutive, but not inducible NOS expression in the brains of mice infected with the LP-BM5 leukemia virus

A. Basile, Y. Sei, Y. Kustova, 1997, Brain Research.

The protective effects of stress control may be mediated by increased brain levels of benzodiazepine receptor agonists

R. Drugan, R. J. Ferland, A. Basile, 1994, Brain Research.

Deletion of the GABA(A) receptor beta 3 subunit eliminates the hypnotic actions of oleamide in mice.

W. Mendelson, G. Homanics, A. Basile, 2001, NeuroReport.

A gas chromatographic-mass spectral assay for the quantitative determination of oleamide in biological fluids.

H. Fales, A. Basile, L. Hanus, 1999, Analytical biochemistry.

The Hypnotic Actions of the Fatty Acid Amide, Oleamide

W. Mendelson, A. Basile, 2001, Neuropsychopharmacology.

Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function

S. Barger, A. Basile, Steven W. Barger, 2001, Journal of neurochemistry.

M2 Muscarinic Acetylcholine Receptor Knock-Out Mice Show Deficits in Behavioral Flexibility, Working Memory, and Hippocampal Plasticity

J. Wess, C. Alzheimer, T. Miyakawa, 2004, The Journal of Neuroscience.

Effect of DOV 102,677 on the volitional consumption of ethanol by Myers' high ethanol-preferring rat.

B. McMillen, A. Basile, H. Williams, 2007, Alcoholism, clinical and experimental research.

Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.

P. Czobor, P. Skolnick, P. Popik, 2006, CNS drug reviews.

Pharmacological Profile of the “Triple” Monoamine Neurotransmitter Uptake Inhibitor, DOV 102,677

A. Janowsky, P. Skolnick, P. Popik, 2006, Cellular and Molecular Neurobiology.

Anxioselective anxiolytics: can less be more?

P. Skolnick, A. Lippa, A. Basile, 2004, European Journal of Pharmacology.

The Anxioselective Agent 7-(2-Chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) Is More Efficacious Than Diazepam at Enhancing GABA-Gated Currents at α1 Subunit-Containing GABAA Receptors

P. Skolnick, P. Popik, G. Nowak, 2006, Journal of Pharmacology and Experimental Therapeutics.

Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy.

C. Yurdaydın, G. Nowak, A. Basile, 1993, The Journal of pharmacology and experimental therapeutics.

Characterization of the Antinociceptive Actions of Bicifadine in Models of Acute, Persistent, and Chronic Pain

A. Janowsky, P. Skolnick, P. Popik, 2007, Journal of Pharmacology and Experimental Therapeutics.

Elevated Brain Concentrations of 1, 4-Benzodiazepines in Fulminant Hepatic Failure

L. Pannell, P. Skolnick, Roger Williams, 1992 .

Differential sensitivity of cerebellar purkinje neurons to ethanol in selectivity outbred lines of mice: maintenance in vitro independent of synaptic transmission

T. Dunwiddie, B. Hoffer, A. Basile, 1983, Brain Research.

Increased glutamate in CSF and plasma of patients with HIV dementia.

R. Heaton, R. Ellis, A. Basile, 2002, Neurology.

“Peripheral” benzodiazepine binding sites in the maudsley reactive rat: Selective decrease confined to peripheral tissues

S. Paul, J. Crawley, R. Drugan, 1987, Brain Research Bulletin.

Localization and pharmacological characterization of pigeon diazepam-insensitive GABAA receptors

J. Witkin, A. Basile, G. Wong, 1997, Neuroscience.

The involvement of the benzodiazepine receptor in hepatic encephalopathy: evidence for the presence of a benzodiazepine receptor ligand.

P. Skolnick, A. Basile, E. Jones, 1990, Advances in biochemical psychopharmacology.

Flumazenil: potential implications for hepatic encephalopathy.

A. Basile, K. Mullen, E. Jones, 1990, Pharmacology & therapeutics.

The Triple Uptake Inhibitor (1R,5S)-(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0] Hexane Hydrochloride (DOV 21947) Reduces Body Weight and Plasma Triglycerides in Rodent Models of Diet-Induced Obesity

M. Tschöp, P. Skolnick, L. Shearman, 2008, Journal of Pharmacology and Experimental Therapeutics.

Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia

R. Lin, P. Skolnick, A. Basile, 1994, Neuroscience Letters.

Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. Implications for treatment with benzodiazepine receptor antagonists.

A. Basile, S. H. Gammal, 1988, Clinical neuropharmacology.

T. R. Johnson, R. Schachar, A. Basile, 2010 .

Role for M5 muscarinic acetylcholine receptors in cocaine addiction

J. Wess, A. Fink-Jensen, D. McKinzie, 2003, Journal of neuroscience research.

The use of brain slices in central nervous system pharmacology.

T. Dunwiddie, A. Basile, A. Mueller, 1983, Federation proceedings.

Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia

J. Wess, A. Duttaroy, A. Zapata, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology.

J. Wess, C. Deng, A. Duttaroy, 2003, Life sciences.

Population pharmacokinetics of pegaptanib sodium (Macugen®) in patients with diabetic macular edema

M. Hutmacher, K. Kowalski, A. Basile, 2015, Clinical ophthalmology.

The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease

M. Rudd, J. Masdeu, G. Bormans, 2022, Science Translational Medicine.

Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury.

A. Faden, J. Allen, A. Basile, 1999, The Journal of pharmacology and experimental therapeutics.

The involvement of benzodiazepine receptor ligands in hepatic encephalopathy

A. Basile, H. Fisch, P. Schoch, 1994, Hepatology.

IgG Isolated from LP-BM5 Infected Mouse Brain Activates Ionotropic Glutamate Receptors

P. Usherwood, M. Rogawski, S. Rizzoli, 2001, Neurobiology of Disease.

Regional disease in AMPA receptor density in mice infected with the LP‐BM5 murine leukemia virus

A. Basile, Y. Sei, M. Espey, 1997 .

Regional decreases [corrected] in AMPA receptor density in mice infected with the LP-BM5 murine leukemia virus.

A. Basile, Y. Sei, M. Espey, 1997, Neuroreport.

Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning.

R. Drugan, R. J. Ferland, A. Basile, 1997, Brain research. Brain research protocols.

Modulation of melphalan resistance in glioma cells with a peripheral benzodiazepine receptor ligand-melphalan conjugate.

H. Friedman, J. Gallo, A. Basile, 1997, Journal of medicinal chemistry.

Regulation of renal peripheral benzodiazepine receptors by anion transport inhibitors.

P. Skolnick, A. Basile, H. Lueddens, 1988, Life sciences.

Electrophysiological responses to adenosine analogs in rat hippocampus and cerebellum: evidence for mediation by adenosine receptors of the A1 subtype.

T. Dunwiddie, M. Palmer, A. Basile, 1984, Life sciences.

Preservation of "peripheral" benzodiazepine receptors: differential effects of freezing on [3H]Ro 5-4864 and [3H]PK 11195 binding.

P. Skolnick, A. Basile, 1987, Journal of pharmacological methods.

The involvement of benzodiazepine receptor ligands in hepatic encephalopathy

A. Basile, H. Fisch, P. Schoch, 1994, Hepatology.

Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy

R. Hughes, A. Basile, Roger Williams, 1994, Hepatology.

The GABAA receptor complex in hepatic encephalopathy. Autoradiographic evidence for the presence of elevated levels of a benzodiazepine receptor ligand.

P. Skolnick, A. Basile, E. Jones, 1990, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Aldosterone-reversible decrease in the density of renal peripheral benzodiazepine receptors in the rat after adrenalectomy.

P. Skolnick, A. Basile, N. Ostrowski, 1987, The Journal of pharmacology and experimental therapeutics.

Adrenalectomy reduces the density of 'peripheral-type' binding sites for benzodiazepines in the rat kidney.

S. Paul, P. Skolnick, A. Basile, 1985, European journal of pharmacology.

Ammonia and GABA‐ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy

A. Basile, E. Jones, 1997, Hepatology.

A Pulmonary Formulation of l-Dopa Enhances Its Effectiveness in a Rat Model of Parkinson's Disease

T. Cooper, R. Bartus, E. Lo, 2004, Journal of Pharmacology and Experimental Therapeutics.

Preclinical Evaluation of the Abuse Potential of the Analgesic Bicifadine

P. Skolnick, K. Nicholson, A. Basile, 2009, Journal of Pharmacology and Experimental Therapeutics.

Norepinephrine elicits both excitatory and inhibitory responses from Purkinje cells in the in vitro rat cerebellar slice.

T. Dunwiddie, A. Basile, 1984, Brain research.

Direct enhancement of GABA-ergic neurotransmission by ammonia.

A. Basile, S. Knauer, J. Ha, 1997, Advances in experimental medicine and biology.

Population pharmacokinetics of pegaptanib sodium (Macugen®) in patients with diabetic macular edema

M. Hutmacher, K. Kowalski, A. Basile, 2015, Clinical ophthalmology.